FDA Expects Class III Device Imports From China
This article was originally published in The Gray Sheet
Executive Summary
As Chinese companies take market share from multinationals in China in some high-risk implantable device categories, FDA's device representative in Beijing says the agency expects to see made-in-China class III devices enter the U.S. Chinese manufacturers, however, face a number of hurdles before this can become reality.